Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957

Watchlist Manager
Yunnan Botanee Bio-Technology Group Co Ltd Logo
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Watchlist
Price: 40.37 CNY -3.67% Market Closed
Market Cap: 17.1B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Yunnan Botanee Bio-Technology Group Co Ltd stock under the Base Case scenario is 64.04 CNY. Compared to the current market price of 40.37 CNY, Yunnan Botanee Bio-Technology Group Co Ltd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
64.04 CNY
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
92
vs Industry
14
Median 3Y
7.1
Median 5Y
9.5
Industry
1
Forward
2.7
More Details
28.9
P/E
P/E
Price to Earnings
28.9
vs History
80
vs Industry
16
Median 3Y
37.4
Median 5Y
45.4
Industry
16.4
Forward
23.5
More Details
34.7
P/OCF
P/OCF
Price to OCF
34.7
vs History
90
vs Industry
8
Median 3Y
48.9
Median 5Y
59.7
Industry
11.5
More Details
26
P/FCFE
P/FCFE
Price to FCFE
26
vs History
90
vs Industry
19
Median 3Y
68.9
Median 5Y
81.2
Industry
17.6
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
90
vs Industry
16
Median 3Y
6.7
Median 5Y
8.5
Industry
1.5
More Details
2.4
EV/S
EV/S
Enterprise Value to Sales
2.4
vs History
92
vs Industry
18
Median 3Y
6.4
Median 5Y
8.9
Industry
1.1
Forward
2.3
More Details
3.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.4
vs History
92
vs Industry
42
Median 3Y
8.7
Median 5Y
12
Industry
3.7
More Details
23.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.9
vs History
80
vs Industry
11
Median 3Y
32.1
Median 5Y
40.5
Industry
9.6
Forward
15.6
More Details
23.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.9
vs History
80
vs Industry
15
Median 3Y
32.1
Median 5Y
40.5
Industry
12.5
Forward
23.6
More Details
30
EV/OCF
EV/OCF
Enterprise Value to OCF
30
vs History
90
vs Industry
10
Median 3Y
44.7
Median 5Y
57.4
Industry
11.9
More Details
126.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
126.4
vs History
41
vs Industry
2
Median 3Y
122.8
Median 5Y
126.7
Industry
15.1
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
92
vs Industry
13
Median 3Y
11.8
Median 5Y
15.6
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Yunnan Botanee Bio-Technology Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
17.1B CNY 2.8 28.9 23.9 23.9
FR
L'Oreal SA
PAR:OR
199.9B EUR 4.6 31.2 19.2 23.3
UK
Unilever PLC
LSE:ULVR
116.1B GBP 2.2 23.7 146.6 169.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.7 51.5 36.1 39.7
UK
HALEON PLC
LSE:HLN
34.2B GBP 3 23.7 14.1 15.9
DE
Beiersdorf AG
XETRA:BEI
26.8B EUR 2.7 29.3 12.4 15.1
US
Estee Lauder Companies Inc
NYSE:EL
21.4B USD 1.4 -30.5 11.3 17.6
JP
Kao Corp
TSE:4452
2.8T JPY 1.7 26.1 11.2 18
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9.2 -286.1 42.2 45.3
CN
Giant Biogene Holding Co Ltd
HKEX:2367
79.3B HKD 13.4 36.1 27.9 28.4
IN
Dabur India Ltd
NSE:DABUR
858.9B INR 6.8 47.8 35.8 43.7
P/E Multiple
Earnings Growth PEG
CN
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Average P/E: 33.1
28.9
12%
2.4
FR
L'Oreal SA
PAR:OR
31.2
9%
3.5
UK
Unilever PLC
LSE:ULVR
23.7
14%
1.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51.5
9%
5.7
UK
HALEON PLC
LSE:HLN
23.7
13%
1.8
DE
Beiersdorf AG
XETRA:BEI
29.3
12%
2.4
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -30.5
43%
N/A
JP
Kao Corp
TSE:4452
26.1
10%
2.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -286.1 N/A N/A
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
36.1
25%
1.4
IN
Dabur India Ltd
NSE:DABUR
47.8
9%
5.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 250,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.